Why the study?
Mutations in K ATP channels impair their regulatory roles in disease, but patients with these mutations still lack efficient treatment.
Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May reduce EAD arrhythmias via cardiomyocyte KATP activation; leaves open clinical translation pending prospective human data.
Wang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: